• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

精神分裂症生物学标志物的选择性综述。

A selective review of biological markers in schizophrenia.

作者信息

Szymanski S, Kane J M, Lieberman J A

机构信息

Psychiatry Research Department, Hillside Hospital, Glen Oaks, NY 11004.

出版信息

Schizophr Bull. 1991;17(1):99-111. doi: 10.1093/schbul/17.1.99.

DOI:10.1093/schbul/17.1.99
PMID:1675484
Abstract

Through previous research, promising biological markers for schizophrenia have been identified. Abnormalities in eye movement, electrodermal activity, event-related brain potentials, attention and informational processing, and brain imaging have been reported. Studies of potential trait markers suffer from the lack of a standardized methodology, which makes comparisons of their results difficult. No one possible marker appears specific for schizophrenia. Additional studies in high-risk children and adults are needed using multiple measurements to define biologic similarities and differences between psychiatric syndromes in order to develop definitive trait markers for schizophrenia. Sufficient evidence does not exist to support the inclusion of biological markers among the DSM-IV criteria for schizophrenia, although some are sufficiently robust to merit mention among the associated features discussed in the text.

摘要

通过先前的研究,已确定了有前景的精神分裂症生物标志物。已有报告称眼动、皮肤电活动、事件相关脑电位、注意力和信息处理以及脑成像存在异常。对潜在特质标志物的研究因缺乏标准化方法而受到影响,这使得对其结果进行比较变得困难。没有一种可能的标志物似乎对精神分裂症具有特异性。需要对高危儿童和成人进行更多研究,采用多种测量方法来确定精神疾病综合征之间的生物学异同,以便开发出精神分裂症的确切特质标志物。虽然有一些生物标志物足够可靠,值得在文本讨论的相关特征中提及,但尚无充分证据支持将其纳入精神分裂症的《精神疾病诊断与统计手册》第四版标准。

相似文献

1
A selective review of biological markers in schizophrenia.精神分裂症生物学标志物的选择性综述。
Schizophr Bull. 1991;17(1):99-111. doi: 10.1093/schbul/17.1.99.
2
[Neurobiology of schizophrenia].[精神分裂症的神经生物学]
Schweiz Arch Neurol Psychiatr (1985). 1995;146(5):224-9.
3
Symptom dimensions of schizophrenia: a selective integration of neurophysiological and neuropsychological correlates.
Neuropsychobiology. 1996;34(4):192-200. doi: 10.1159/000119310.
4
Considerations on "organic" exclusion criteria for schizophrenia.关于精神分裂症“器质性”排除标准的思考
Schizophr Bull. 1991;17(1):69-73. doi: 10.1093/schbul/17.1.69.
5
Magnetic resonance imaging in schizophrenia: altered brain morphology associated with P300 abnormalities and eye tracking dysfunction.精神分裂症的磁共振成像:与P300异常和眼动追踪功能障碍相关的脑形态改变。
Biol Psychiatry. 1991 Oct 15;30(8):753-69. doi: 10.1016/0006-3223(91)90232-b.
6
Neurobiological substrate of dimensions of schizophrenic illness.
J Psychiatr Res. 1995 Jul-Aug;29(4):255-60. doi: 10.1016/0022-3956(95)00028-4.
7
Schizophrenic syndromes and frontal lobe performance.精神分裂症综合征与额叶功能表现
Br J Psychiatry. 1991 Mar;158:340-5. doi: 10.1192/bjp.158.3.340.
8
Subtype progression and pathophysiologic deterioration in early schizophrenia.早期精神分裂症的亚型进展与病理生理恶化
Schizophr Bull. 1993;19(1):71-84. doi: 10.1093/schbul/19.1.71.
9
Premorbid adjustment as a predictor of phenomenological and neurobiological indices in schizophrenia.病前适应作为精神分裂症现象学和神经生物学指标的预测因素
Schizophr Res. 1995 Aug 15;16(3):189-97. doi: 10.1016/0920-9964(94)00073-h.
10
Commentary on the Modified Rogers Scale and the 'conflict of paradigms' hypothesis.
Br J Psychiatry. 1991 Mar;158:337-9. doi: 10.1192/bjp.158.3.337.

引用本文的文献

1
Subchronic oral administration of crude khat extract (Catha edulis forsk) induces schizophernic-like symptoms in mice.卡塔叶粗提物(Catha edulis forsk)的亚慢性口服给药可诱导小鼠出现精神分裂症样症状。
BMC Complement Altern Med. 2016 May 31;16:153. doi: 10.1186/s12906-016-1145-6.
2
SPEM dysfunction and general schizotypy as measured by the SSQ: a controlled study.通过社交分裂症问卷(SSQ)测量的特殊感知觉加工障碍(SPEM)功能障碍与一般分裂型特质:一项对照研究。
BMC Neurol. 2009 Jun 29;9:27. doi: 10.1186/1471-2377-9-27.
3
Exploratory eye movement dysfunction as a discriminator for schizophrenia : a large sample study using a newly developed digital computerized system.
探索性眼球运动功能障碍作为精神分裂症的鉴别指标:一项使用新开发的数字计算机系统的大样本研究
Eur Arch Psychiatry Clin Neurosci. 2009 Apr;259(3):186-94. doi: 10.1007/s00406-008-0850-7. Epub 2009 Jan 22.
4
[123I] ADAM brainstem binding correlates with the loudness dependence of auditory evoked potentials.[123I] 去整合素金属蛋白酶(ADAM)脑干结合与听觉诱发电位的响度依赖性相关。
Eur Arch Psychiatry Clin Neurosci. 2008 Feb;258(1):40-7. doi: 10.1007/s00406-007-0760-0. Epub 2007 Nov 7.
5
Biomarkers for the effects of antipsychotic drugs in healthy volunteers.抗精神病药物对健康志愿者影响的生物标志物。
Br J Clin Pharmacol. 2001 Feb;51(2):119-32. doi: 10.1111/j.1365-2125.2001.01308.x.
6
Smooth pursuit eye tracking dysfunction in schizophrenia: subcortical implications.精神分裂症中的平稳跟踪眼球追踪功能障碍:皮层下的影响。
J Psychiatry Neurosci. 1991 Sep;16(3):123-30.